Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMC 3041778)

Published in BMC Cancer on February 04, 2011

Authors

Katja Linher-Melville1, Stephanie Zantinge, Toran Sanli, Hertzel Gerstein, Theodoros Tsakiridis, Gurmit Singh

Author Affiliations

1: Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.

Articles citing this

Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells. PLoS One (2012) 1.38

AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway. Cancer Biol Ther (2013) 1.28

Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies. Cancer Immunol Res (2015) 0.98

The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells. BMC Cancer (2014) 0.89

Effect of maternal obesity on estrous cyclicity, embryo development and blastocyst gene expression in a mouse model. Hum Reprod (2012) 0.87

A bioenergetic profile of non-transformed fibroblasts uncovers a link between death-resistance and enhanced spare respiratory capacity. Mitochondrion (2013) 0.85

Obesity and cancer progression: is there a role of fatty acid metabolism? Biomed Res Int (2015) 0.84

Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer. Cell Death Dis (2016) 0.81

Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer. Oncotarget (2016) 0.77

Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells. JCI Insight (2017) 0.75

Prolactin activation of the long form of its cognate receptor causes increased visceral fat and obesity in males as shown in transgenic mice expressing only this receptor subtype. Horm Metab Res (2011) 0.75

Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells. Neuro Oncol (2016) 0.75

Platelets from pulmonary hypertension patients show increased mitochondrial reserve capacity. JCI Insight (2017) 0.75

Metabolic fate of docosahexaenoic acid (DHA; 22:6n-3) in human cells: direct retroconversion of DHA to eicosapentaenoic acid (20:5n-3) dominates over elongation to tetracosahexaenoic acid (24:6n-3). FEBS Lett (2016) 0.75

Expression of STK11 gene and its promoter activity in MCF control and cancer cells. 3 Biotech (2017) 0.75

Articles cited by this

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

On the origin of cancer cells. Science (1956) 49.55

Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest (2001) 23.21

Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol (2003) 12.91

Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab (2005) 8.30

The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem (1997) 6.04

Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett (2003) 5.22

AMP-activated protein kinase--development of the energy sensor concept. J Physiol (2006) 4.93

AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans (2003) 3.72

Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition (2000) 3.58

Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol (2000) 3.27

AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol (2006) 3.11

The role of prolactin in mammary carcinoma. Endocr Rev (2003) 2.95

Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest (2009) 2.80

Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta (2009) 2.70

Critical phosphorylation sites for acetyl-CoA carboxylase activity. J Biol Chem (1994) 2.19

Key stages in mammary gland development. Secretory activation in the mammary gland: it's not just about milk protein synthesis! Breast Cancer Res (2007) 2.15

Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J Biol Chem (2002) 2.11

A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci U S A (2006) 2.03

Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J Biol Chem (1997) 1.98

Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int J Radiat Oncol Biol Phys (2010) 1.89

Malonyl-CoA binding site and the overt carnitine palmitoyltransferase activity reside on the opposite sides of the outer mitochondrial membrane. Proc Natl Acad Sci U S A (1987) 1.82

Characterization of a novel metabolic strategy used by drug-resistant tumor cells. FASEB J (2002) 1.76

A rapid spectrophotometric assay for carnitine palmitoyltransferase. Anal Biochem (1972) 1.73

Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res (1997) 1.70

Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res (1996) 1.69

Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem (2004) 1.64

Regulation of transcription by AMP-activated protein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors. J Biol Chem (2001) 1.61

Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir. Int J Cancer (2008) 1.55

Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am J Pathol (1995) 1.51

Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase. Biochim Biophys Acta (1992) 1.50

Prolactin synthesis and secretion by human breast cancer cells. Cancer Res (1995) 1.49

The role of PPARalpha in lipid metabolism and obesity: focusing on the effects of estrogen on PPARalpha actions. Pharmacol Res (2009) 1.38

Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms. Nucl Recept (2005) 1.32

Some differences in the properties of carnitine palmitoyltransferase activities of the mitochondrial outer and inner membranes. Biochem J (1987) 1.21

The regulation of fatty acid synthase by STAT5A. Diabetes (2005) 1.16

Lipid synthesis in lactation: diet and the fatty acid switch. J Mammary Gland Biol Neoplasia (2007) 1.15

Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification. Am J Physiol Endocrinol Metab (2006) 1.13

Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75. Breast Cancer Res Treat (2007) 1.09

The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J Clin Invest (1998) 1.01

AMP-activated protein kinase and hepatic genes involved in glucose metabolism. Biochem Soc Trans (2003) 1.01

Detection of prolactin messenger RNA in mammary and other normal and neoplastic tissues by polymerase chain reaction. Lab Invest (1993) 1.01

Carnitine palmitoyltransferase I in human carcinomas: a novel role in histone deacetylation? Cancer Biol Ther (2007) 0.98

Dietary l-carnitine stimulates carnitine acyltransferases in the liver of aged rats. J Histochem Cytochem (2002) 0.95

Complex prolactin crosstalk in breast cancer: new therapeutic implications. Mol Cell Endocrinol (2009) 0.89

STAT5 binding contributes to lactational stimulation of promoter III expressing the bovine acetyl-CoA carboxylase alpha-encoding gene in the mammary gland. J Mol Endocrinol (2002) 0.88

Mammary gland development and the prolactin receptor. Adv Exp Med Biol (2000) 0.88

Prolactin suppresses malonyl-CoA concentration in human adipose tissue. Horm Metab Res (2009) 0.87

In vitro studies of a prolactin antagonist, hPRL-G129R in human breast cancer cells. Int J Oncol (2001) 0.85

Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitine. Eur J Nutr (2005) 0.83

Regulation by oestrogen of carnitine palmitoyltransferase in hepatic mitochondria. Biochem J (1986) 0.82

Serum immunoreactive and bioactive lactogenic hormones in advanced breast cancer patients treated with bromocriptine and octreotide. Eur J Cancer (1993) 0.82

Estrogen, lipid oxidation, and body fat. N Engl J Med (1995) 0.81

Articles by these authors

Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation (2006) 3.38

Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am Heart J (2007) 3.12

Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial. CMAJ (2009) 2.58

Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney. Eur Urol (2008) 2.42

Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int J Radiat Oncol Biol Phys (2010) 1.89

The economic cost of diabetes in Canada, 1998. Diabetes Care (2002) 1.71

Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care (2010) 1.66

Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology (2014) 1.47

Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells. PLoS One (2012) 1.38

Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells. Photochem Photobiol (2005) 1.37

Overexpression of vimentin: role in the invasive phenotype in an androgen-independent model of prostate cancer. Cancer Res (2003) 1.32

Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem Biophys Res Commun (2008) 1.24

Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation (2003) 1.23

Can family physicians help patients initiate basal insulin therapy successfully?: randomized trial of patient-titrated insulin glargine compared with standard oral therapy: lessons for family practice from the Canadian INSIGHT trial. Can Fam Physician (2008) 1.18

ets-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element. FASEB J (2005) 1.18

Toward Fairness in Data Sharing. N Engl J Med (2016) 1.14

Doxycycline and other tetracyclines in the treatment of bone metastasis. Anticancer Drugs (2003) 1.13

Giant cell tumor of bone: a basic science perspective. Bone (2012) 1.11

Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer. Cancer Res (2002) 1.10

Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. Neoplasia (2007) 1.05

Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer. Can J Physiol Pharmacol (2010) 1.01

Cancer cell lines release glutamate into the extracellular environment. Clin Exp Metastasis (2009) 1.00

Cancer cells release glutamate via the cystine/glutamate antiporter. Biochem Biophys Res Commun (2009) 0.99

Properties of the stromal cell in giant cell tumor of bone. Clin Orthop Relat Res (2007) 0.98

Shared electronic vascular risk decision support in primary care: Computerization of Medical Practices for the Enhancement of Therapeutic Effectiveness (COMPETE III) randomized trial. Arch Intern Med (2011) 0.98

Regulation of the cell cycle in response to inhibition of mitochondrial generated energy. Biochem Biophys Res Commun (2005) 0.97

Role of IGF-1/IGF-1R in regulation of invasion in DU145 prostate cancer cells. Cancer Cell Int (2008) 0.96

A family-based intervention to promote healthy lifestyles in an aboriginal community in Canada. Can J Public Health (2008) 0.96

Ionizing radiation regulates the expression of AMP-activated protein kinase (AMPK) in epithelial cancer cells: modulation of cellular signals regulating cell cycle and survival. Radiother Oncol (2012) 0.95

High activity of mitochondrial glycerophosphate dehydrogenase and glycerophosphate-dependent ROS production in prostate cancer cell lines. Biochem Biophys Res Commun (2005) 0.95

The importance of social and collaborative learning for online continuing medical education (OCME): directions for future development and research. Med Teach (2012) 0.95

Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors. J Lab Clin Med (2006) 0.94

Chronic hypoxia promotes an aggressive phenotype in rat prostate cancer cells. Free Radic Res (2007) 0.93

Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways. Radiat Oncol (2011) 0.92

Design, synthesis, and evaluation of novel 6-chloro-/fluorochromone derivatives as potential topoisomerase inhibitor anticancer agents. Bioorg Med Chem Lett (2005) 0.92

Causal relationship between adiponectin and metabolic traits: a Mendelian randomization study in a multiethnic population. PLoS One (2013) 0.92

Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy. Cancer Res (2002) 0.90

Observations on the use of the avian chorioallantoic membrane (CAM) model in investigations into angiogenesis. Curr Drug Targets Cardiovasc Haematol Disord (2003) 0.90

Upregulation of MMP-13 via Runx2 in the stromal cell of Giant Cell Tumor of bone. Bone (2009) 0.90

Ets-1 global gene expression profile reveals associations with metabolism and oxidative stress in ovarian and breast cancers. Cancer Metab (2013) 0.90

Prediction and analysis of paralogous proteins in Trichomonas vaginalis genome. Bioinformation (2011) 0.90

Simultaneous determination of (fluoro)quinolone antibiotics in kidney, marine products, eggs, and muscle by enzyme-linked immunosorbent assay (ELISA). J Agric Food Chem (2006) 0.90

Collagenase expression and activity in the stromal cells from giant cell tumour of bone. Bone (2009) 0.89

Ets-1 regulates energy metabolism in cancer cells. PLoS One (2010) 0.89

Association of phosphorylated epidermal growth factor receptor with survival in patients with locally advanced non-small cell lung cancer treated with radiotherapy. J Thorac Oncol (2008) 0.89

Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells. Anticancer Drugs (2009) 0.89

Relationship between mTHPC fluorescence photobleaching and cell viability during in vitro photodynamic treatment of DP16 cells. Photochem Photobiol (2002) 0.89

Glutamate signaling in healthy and diseased bone. Front Endocrinol (Lausanne) (2012) 0.88

Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells. Biochem Biophys Res Commun (2011) 0.88

Lovastatin sensitizes lung cancer cells to ionizing radiation: modulation of molecular pathways of radioresistance and tumor suppression. J Thorac Oncol (2011) 0.88

Role of the transcription factor Ets-1 in cisplatin resistance. Mol Cancer Ther (2004) 0.88

Increased occurrence of diabetes in people with ischemic cardiovascular disease and general and abdominal obesity. Can J Cardiol (2003) 0.87

Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: a mechanistic model supporting prevention strategies. Int J Oncol (2010) 0.86

Increased expression of mitochondrial glycerophosphate dehydrogenase and antioxidant enzymes in prostate cancer cell lines/cancer. Free Radic Res (2007) 0.86

Up-regulation of Hsp27 plays a role in the resistance of human colon carcinoma HT29 cells to photooxidative stress. Photochem Photobiol (2002) 0.85

Role of insulin-like growth factor binding proteins (IGFBPs) in breast cancer proliferation and metastasis. Clin Exp Metastasis (2003) 0.85

PTHrP induces autocrine/paracrine proliferation of bone tumor cells through inhibition of apoptosis. PLoS One (2011) 0.85

Characterization of a rat model of metastatic prostate cancer bone pain. J Pain Res (2010) 0.84

PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone. J Orthop Res (2011) 0.84

Effect of Herceptin on the development and progression of skeletal metastases in a xenograft model of human breast cancer. Oncogene (2005) 0.84

Extracellular glutamate alters mature osteoclast and osteoblast functions. Can J Physiol Pharmacol (2010) 0.84

Individualized electronic decision support and reminders can improve diabetes care in the community. AMIA Annu Symp Proc (2005) 0.84

ETS proteins and MMPs: partners in invasion and metastasis. Curr Drug Targets (2002) 0.84

Potential therapeutic drug target identification in Community Acquired-Methicillin Resistant Staphylococcus aureus (CA-MRSA) using computational analysis. Bioinformation (2012) 0.84

Inhibition by doxycycline of angiogenesis in the chicken chorioallantoic membrane (CAM). Cancer Chemother Pharmacol (2005) 0.83

Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone. Hum Pathol (2010) 0.83

Evaluation of single amino acid chelate derivatives and regioselective radiolabelling of a cyclic peptide for the urokinase plasminogen activator receptor. Nucl Med Biol (2009) 0.82

AP-1 as a Regulator of MMP-13 in the Stromal Cell of Giant Cell Tumor of Bone. Biochem Res Int (2011) 0.82

Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells. Breast Cancer Res Treat (2002) 0.82

Metabolic pathway analysis and molecular docking analysis for identification of putative drug targets in Toxoplasma gondii: novel approach. Bioinformation (2012) 0.81

Chronic modulation of AMP-Kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts. Radiat Oncol (2012) 0.80

Activation of the stress-activated JNK and p38 MAP kinases in human cells by Photofrin-mediated photodynamic therapy. J Photochem Photobiol B (2003) 0.80

Examination of the mechanisms of osteolysis in patients with metastatic breast cancer. Oncol Rep (2009) 0.80

Increased skeletal muscle glucose uptake by rosemary extract through AMPK activation. Appl Physiol Nutr Metab (2014) 0.80

Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity. J Lab Clin Med (2004) 0.80

Androgen-dependent regulation of medium and long chain fatty acids uptake in prostate cancer. Prostate (2007) 0.80

JNK1 activity lowers the cellular production of H2O2 and modulates the growth arrest response to scavenging of H2O2 by catalase. Exp Cell Res (2003) 0.79

Genetic information and the prediction of incident type 2 diabetes in a high-risk multiethnic population: the EpiDREAM genetic study. Diabetes Care (2013) 0.79

Quantification of anti-angiogenesis using the capillaries of the chick chorioallantoic membrane demonstrates that the effect of human angiostatin is age-dependent. Microvasc Res (2004) 0.78

Matrix Metalloproteinase Activity in the Stromal Cell of Giant Cell Tumor of Bone. Open Bone J (2009) 0.78

Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells. Photochem Photobiol (2005) 0.78

Oxidative stress and cancer pain. Can J Physiol Pharmacol (2013) 0.78

The role of TWIST as a regulator in giant cell tumor of bone. J Cell Biochem (2011) 0.78

Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells. Mol Cell Biochem (2015) 0.78

Molecular modeling, dynamics studies and virtual screening of Fructose 1, 6 biphosphate aldolase-II in community acquired- methicillin resistant Staphylococcus aureus (CA-MRSA). Bioinformation (2013) 0.78

Changes in trabecular bone microarchitecture in postmenopausal women with and without type 2 diabetes: a two year longitudinal study. BMC Musculoskelet Disord (2013) 0.77

Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model. Cardiovasc Pathol (2007) 0.77

Inhibition of human lung cancer cell proliferation and survival by wine. Cancer Cell Int (2014) 0.77

Increased BNip3 and decreased mutant p53 in cisplatin-sensitive PDT-resistant HT29 cells. Biochem Biophys Res Commun (2005) 0.77